Efficacy and Safety of a 3‐Weekly TS ‐1 Adjuvant Regimen in Advanced Gastric Cancer: A Pilot Study
Jihong Bae, Joo‐Hwan Park, Young Saing Kim, Hee Kyung Ahn, Eun Kyung Cho, Dong Bok Shin, Ji‐Hyeon Park, Jun‐Young Yang, Woon Kee Lee, Sun Jin Sym
Cancer Medicine
초록
Our study revealed that the 3-weekly TS-1 regimen as adjuvant therapy exhibited good efficacy and manageable toxicity. This regimen as an adjuvant therapy for AGC should be evaluated in future studies.